Q: What is Orencia used for?

Orencia is used to treat: rheumatoid arthritis juvenile idiopathic arthritis psoriatic arthritis

Q: How does Orencia work?

Targeting the Immune System Orencia belongs to a class of medications known as selective costimulation modulators. It is designed to interfere with the process that triggers inflammation in the body. In conditions like rheumatoid arthritis and psoriatic arthritis, the immune system mistakenly attacks healthy joints and tissues. How T-Cells Are Affected The medication specifically targets T-cells, which are a type of white blood cell involved in the body's immune response. For a T-cell to become fully active and cause inflammation, it usually requires two separate signals from other cells. Orencia works by: Binding to specific proteins on the surface of cells that communicate with T-cells. Blocking the second signal necessary for T-cell activation. Preventing the T-cells from sending out chemical messages that lead to pain and swelling. By keeping these T-cells in an inactive state, Orencia helps to lower the overall inflammatory response. This can lead to a reduction in symptoms and may help slow down the progression of joint damage over time.

Q: What are the active ingredients in Orencia?

The active ingredient in Orencia is abatacept .

Q: What are the side effects of Orencia?

Common side effects of Orencia may include: Upper respiratory tract infection Headache Nausea Always consult with a healthcare professional about potential side effects.

Q: What drug class is Orencia?

Orencia belongs to the selective T-cell costimulation modulator drug class.

Q: What is the dosage of Orencia and how do I take it?

Administration Methods Orencia is available in two forms: an injection given under the skin (subcutaneous) and an infusion delivered directly into a vein (intravenous). Subcutaneous Injection Subcutaneous injections are typically administered once a week. Patients or caregivers may be trained by a healthcare professional to give these injections at home. When administering the injection, it is important to: Rotate the injection site each time, using the front of the thighs, the abdomen (avoiding the area around the belly button), or the outer area of the upper arms. Avoid injecting into skin that is tender, bruised, red, or hard. Follow all instructions for the proper disposal of used needles and syringes. Intravenous Infusion The intravenous infusion is performed by a healthcare professional in a clinical setting. The procedure usually takes about 30 minutes. After the initial starting doses, maintenance infusions are typically scheduled once every four weeks. Missed Doses If a dose is missed, contact a healthcare provider to establish a new schedule. Do not use extra medicine or double a dose to make up for a missed one.

Q: Is Orencia safe during pregnancy and breastfeeding?

Pregnancy It is not currently known if Orencia can cause harm to an unborn baby. While animal studies did not show a high risk of birth defects, they did show some changes in the immune systems of offspring exposed to high doses. Because this medication is known to cross the placenta, it may affect the immune system of a developing fetus. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits with your healthcare provider. There is a pregnancy registry available for women who take Orencia during pregnancy to monitor the health of both the mother and the baby. This registry helps researchers understand the effects of the medication on pregnancy outcomes. Breastfeeding It is not known whether Orencia passes into human breast milk or how it might affect a nursing infant. Because many drugs are excreted in human milk and there is a potential for serious adverse reactions in nursing infants, a decision should be made whether to stop nursing or stop the medication, taking into account the importance of the drug to the mother's health. Healthcare providers typically recommend discussing all options for infant feeding if you require treatment with this medication.

Q: What forms and strengths does Orencia come in?

Intravenous Infusion Orencia is supplied as a sterile, preservative-free lyophilized powder in a single-dose vial. This form must be reconstituted and diluted by a healthcare professional before being administered as an intravenous infusion. Subcutaneous Injection Orencia is also available as a solution for subcutaneous injection. It is provided in the following delivery systems: Prefilled Syringe: A single-dose glass syringe equipped with a needle guard. It is available in different strengths to accommodate pediatric and adult dosing. ClickJect Autoinjector: A single-dose, disposable autoinjector designed for use in adults. The solution for injection is clear to slightly opalescent and colorless to pale yellow.

Q: What is the FDA approval status of Orencia?

FDA Approval and Indications Orencia was first approved by the U.S. Food and Drug Administration (FDA) in 2005. It is currently approved for the following uses: Adult Rheumatoid Arthritis: For reducing signs and symptoms and slowing the progression of structural damage in adults with moderately to severely active rheumatoid arthritis. Polyarticular Juvenile Idiopathic Arthritis: For patients 2 years of age and older with moderately to severely active disease. Psoriatic Arthritis: For adults with active psoriatic arthritis. Graft-Versus-Host Disease (GVHD) Prevention: For adults and children 2 years of age and older undergoing hematopoietic stem cell transplantation from an unrelated donor, used in combination with other immunosuppressants. Regulatory Milestones In December 2021, the FDA expanded Orencia's approval to include the prevention of acute graft-versus-host disease. This was a significant regulatory milestone as it was the first drug approved by the FDA for this specific indication. The approval was based on clinical data showing improved survival and reduced risk of severe GVHD in patients receiving the medication alongside standard care. Safety Oversight Orencia does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program. However, the FDA requires specific screening and monitoring for patients using this medication. This includes testing for latent tuberculosis and viral hepatitis before starting treatment, as the drug's effect on the immune system may increase the risk of serious infections. The FDA continues to monitor post-marketing reports regarding the long-term safety profile of the drug, including potential risks of malignancies and severe hypersensitivity reactions.

Question 1

What is Orencia?

Accepted Answer

Orencia is a biologic medication known as a selective T-cell costimulation modulator. It is designed to help control the body's immune response when it mistakenly attacks healthy tissues.

By targeting specific immune cells called T-lymphocytes, the medication helps to decrease inflammation and prevent tissue damage. This action helps to manage the underlying causes of certain chronic inflammatory conditions.

Question 2

What is Orencia used for?

Accepted Answer

Orencia is used to treat:

rheumatoid arthritis
juvenile idiopathic arthritis
psoriatic arthritis

Question 3

How does Orencia work?

Accepted Answer

Targeting the Immune System

Orencia belongs to a class of medications known as selective costimulation modulators. It is designed to interfere with the process that triggers inflammation in the body. In conditions like rheumatoid arthritis and psoriatic arthritis, the immune system mistakenly attacks healthy joints and tissues.

How T-Cells Are Affected

The medication specifically targets T-cells, which are a type of white blood cell involved in the body's immune response. For a T-cell to become fully active and cause inflammation, it usually requires two separate signals from other cells. Orencia works by:

Binding to specific proteins on the surface of cells that communicate with T-cells.
Blocking the second signal necessary for T-cell activation.
Preventing the T-cells from sending out chemical messages that lead to pain and swelling.

By keeping these T-cells in an inactive state, Orencia helps to lower the overall inflammatory response. This can lead to a reduction in symptoms and may help slow down the progression of joint damage over time.

Question 4

What are the active ingredients in Orencia?

Accepted Answer

The active ingredient in Orencia is abatacept.

Question 5

What are the side effects of Orencia?

Accepted Answer

Common side effects of Orencia may include:

Upper respiratory tract infection
Headache
Nausea

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Orencia?

Accepted Answer

Orencia belongs to the selective T-cell costimulation modulator drug class.

Question 7

What is the dosage of Orencia and how do I take it?

Accepted Answer

Administration Methods

Orencia is available in two forms: an injection given under the skin (subcutaneous) and an infusion delivered directly into a vein (intravenous).

Subcutaneous Injection

Subcutaneous injections are typically administered once a week. Patients or caregivers may be trained by a healthcare professional to give these injections at home. When administering the injection, it is important to:

Rotate the injection site each time, using the front of the thighs, the abdomen (avoiding the area around the belly button), or the outer area of the upper arms.
Avoid injecting into skin that is tender, bruised, red, or hard.
Follow all instructions for the proper disposal of used needles and syringes.

Intravenous Infusion

The intravenous infusion is performed by a healthcare professional in a clinical setting. The procedure usually takes about 30 minutes. After the initial starting doses, maintenance infusions are typically scheduled once every four weeks.

Missed Doses

If a dose is missed, contact a healthcare provider to establish a new schedule. Do not use extra medicine or double a dose to make up for a missed one.

Question 8

Is Orencia safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is not currently known if Orencia can cause harm to an unborn baby. While animal studies did not show a high risk of birth defects, they did show some changes in the immune systems of offspring exposed to high doses. Because this medication is known to cross the placenta, it may affect the immune system of a developing fetus.

If you are pregnant or planning to become pregnant, discuss the potential risks and benefits with your healthcare provider. There is a pregnancy registry available for women who take Orencia during pregnancy to monitor the health of both the mother and the baby. This registry helps researchers understand the effects of the medication on pregnancy outcomes.

Breastfeeding

It is not known whether Orencia passes into human breast milk or how it might affect a nursing infant. Because many drugs are excreted in human milk and there is a potential for serious adverse reactions in nursing infants, a decision should be made whether to stop nursing or stop the medication, taking into account the importance of the drug to the mother's health.

Healthcare providers typically recommend discussing all options for infant feeding if you require treatment with this medication.

Question 9

What forms and strengths does Orencia come in?

Accepted Answer

Intravenous Infusion

Orencia is supplied as a sterile, preservative-free lyophilized powder in a single-dose vial. This form must be reconstituted and diluted by a healthcare professional before being administered as an intravenous infusion.

Subcutaneous Injection

Orencia is also available as a solution for subcutaneous injection. It is provided in the following delivery systems:

Prefilled Syringe: A single-dose glass syringe equipped with a needle guard. It is available in different strengths to accommodate pediatric and adult dosing.
ClickJect Autoinjector: A single-dose, disposable autoinjector designed for use in adults.

The solution for injection is clear to slightly opalescent and colorless to pale yellow.

Question 10

What is the FDA approval status of Orencia?

Accepted Answer

FDA Approval and Indications

Orencia was first approved by the U.S. Food and Drug Administration (FDA) in 2005. It is currently approved for the following uses:

Adult Rheumatoid Arthritis: For reducing signs and symptoms and slowing the progression of structural damage in adults with moderately to severely active rheumatoid arthritis.
Polyarticular Juvenile Idiopathic Arthritis: For patients 2 years of age and older with moderately to severely active disease.
Psoriatic Arthritis: For adults with active psoriatic arthritis.
Graft-Versus-Host Disease (GVHD) Prevention: For adults and children 2 years of age and older undergoing hematopoietic stem cell transplantation from an unrelated donor, used in combination with other immunosuppressants.

Regulatory Milestones

In December 2021, the FDA expanded Orencia's approval to include the prevention of acute graft-versus-host disease. This was a significant regulatory milestone as it was the first drug approved by the FDA for this specific indication. The approval was based on clinical data showing improved survival and reduced risk of severe GVHD in patients receiving the medication alongside standard care.

Safety Oversight

Orencia does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program. However, the FDA requires specific screening and monitoring for patients using this medication. This includes testing for latent tuberculosis and viral hepatitis before starting treatment, as the drug's effect on the immune system may increase the risk of serious infections. The FDA continues to monitor post-marketing reports regarding the long-term safety profile of the drug, including potential risks of malignancies and severe hypersensitivity reactions.

Question 11

What should I know about Orencia and cost?

Accepted Answer

Cost Considerations

Orencia is a biologic medication, and its price can be significant. The actual amount a patient pays depends on several factors:

Formulation: The medication is available as a prefilled syringe or autoinjector for subcutaneous use, and as a powder for intravenous infusion. Subcutaneous versions are often used at home, while infusions require a clinical setting, which may add to the overall cost.
Insurance Type: Coverage varies between private insurance, Medicare, and Medicaid. Medicare Part B typically covers infusions administered in a doctor's office, while Part D usually covers the subcutaneous version.
Pharmacy Choice: Specialty pharmacies are often required to dispense biologic medications like Orencia.

Financial Support

Financial assistance may be available through the manufacturer for patients who meet certain eligibility criteria. This can include copay assistance for those with commercial insurance or patient assistance programs for those without adequate coverage. It is recommended to check with the insurance provider and the manufacturer to determine the most accurate out-of-pocket costs.

Orencia

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Orencia

Hospitals.net Disclosure